当前位置:首页 > 股票大全 > 南华生物 000504 财务分析

南华生物财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

南华生物(000504)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入25,973,854.69136,790,924.97104,759,853.1470,433,702.6
营业总成本29,981,563.79157,381,145.47113,192,341.1275,767,566.55
营业利润-2,475,744.55-45,714,087.564,865,711.31-6,405,203.33
利润总额-2,477,564.3-44,709,703.515,870,133.18-5,405,490.16
净利润-2,846,531.87-46,779,971.134,709,236.4-5,821,413.69
其他综合收益----
综合收益总额-2,846,531.87-46,779,971.134,709,236.4-5,821,413.69
南华生物(000504)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计497,830,396.07654,851,149.02419,448,529.08419,313,942.3
非流动资产合计113,472,378.85116,531,367.07122,739,211.11131,343,845.57
资产总计611,302,774.92771,382,516.09542,187,740.19550,657,787.87
流动负债合计294,377,299.49452,396,671.25440,505,099.98461,289,481.87
非流动负债合计15,098,139.0414,311,976.5817,089,203.9415,305,519.82
负债合计309,475,438.53466,708,647.83457,594,303.92476,595,001.69
归属于母公司股东权益合计254,170,544.84256,941,198.3714,257,921.924,798,048.62
股东权益合计301,827,336.39304,673,868.2684,593,436.2774,062,786.18
负债和股东权益合计611,302,774.92771,382,516.09542,187,740.19550,657,787.87
南华生物(000504)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计40,257,981.62207,336,924.72155,278,948.1108,433,482.32
经营活动现金流出小计41,762,725.97171,060,211.19134,854,383.7899,215,225.33
经营活动产生的现金流量净额-1,504,744.3536,276,713.5320,424,564.329,218,256.99
投资活动现金流入小计112,567,193.31340,571,543.34424,144,822.76314,600,713.01
投资活动现金流出小计231,388,510.3327,818,300.11411,644,318.83316,036,312.82
投资活动产生的现金流量净额-118,821,316.9912,753,243.2312,500,503.93-1,435,599.81
筹资活动现金流入小计8,000,000301,703,760.728,000,00018,000,000
筹资活动现金流出小计168,857,327.4175,070,948.1460,813,352.8326,423,545.55
筹资活动产生的现金流量净额-160,857,327.41226,632,812.56-32,813,352.83-8,423,545.55
汇率变动对现金及现金等价物的影响-45.35100.3100.3
现金及现金等价物净增加额-281,183,388.75275,662,814.67111,815.72-640,788.07
期末现金及现金等价物余额212,597,686.65493,781,075.4218,230,076.45217,477,472.66
南华生物000504相关数据
今日股市大盘指数